返回
Relay Therapeutics Inc（RLAY）價格
RLAY 股價走勢圖
RLAY 收益
Relay Therapeutics Inc
$7.35
-3.66%
$-0.28
收盤價：Jan 16, 16:00:00 GMT-5
$7.27
-1.08%
$-0.08
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$7.63
開盤價
$7.73
當日範圍
$7.27 - $7.73
52週區間
$1.77 - $9.04
交易量
2.8M
平均成交量
2.1M
每股盈餘 (TTM)
-1.75
股息收益率
--
市值
$1.2B
什麼是 RLAY？
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company is headquartered in Cambridge, Massachusetts and currently employs 188 full-time employees. The company went IPO on 2020-07-16. The Company’s initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. Its Dynamo platform integrates an array of computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. The Company’s lead product candidates, such as RLY-2608. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including RLY-2608. RLY-2608 is an allosteric, pan-mutant and isoform-selective phosphoinostide 3 kinase alphas (PI3Kα), inhibitor in clinical development. The company is the lead program in its efforts to discover and develop mutant selective inhibitors of PI3Kα.